BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 222 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2023. The put-call ratio across all filers is 2.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $24,971,009 | +13.6% | 231,685 | 0.0% | 0.43% | +23.8% |
| Q1 2024 | $21,977,639 | -23.7% | 231,685 | -25.8% | 0.34% | -26.6% |
| Q4 2023 | $28,813,378 | +30.8% | 312,374 | -28.8% | 0.47% | +18.7% |
| Q3 2023 | $22,021,470 | -20.5% | 438,500 | 0.0% | 0.40% | -15.4% |
| Q2 2023 | $27,713,200 | +40.5% | 438,500 | 0.0% | 0.47% | +29.3% |
| Q1 2023 | $19,728,115 | +2.7% | 438,500 | 0.0% | 0.36% | -4.5% |
| Q4 2022 | $19,210,685 | -33.5% | 438,500 | 0.0% | 0.38% | -33.3% |
| Q3 2022 | $28,893,000 | +30.4% | 438,500 | 0.0% | 0.57% | +19.8% |
| Q2 2022 | $22,149,000 | -41.5% | 438,500 | -26.0% | 0.47% | -20.1% |
| Q1 2022 | $37,849,000 | -10.7% | 592,500 | +49.7% | 0.59% | +9.4% |
| Q4 2021 | $42,394,000 | +15.8% | 395,800 | +11.2% | 0.54% | +12.2% |
| Q3 2021 | $36,600,000 | -9.9% | 356,000 | -22.9% | 0.48% | -11.5% |
| Q2 2021 | $40,612,000 | -9.6% | 461,712 | -0.1% | 0.55% | -18.0% |
| Q1 2021 | $44,920,000 | -13.3% | 462,000 | 0.0% | 0.67% | -16.2% |
| Q4 2020 | $51,813,000 | +21.0% | 462,000 | 0.0% | 0.80% | -5.1% |
| Q3 2020 | $42,827,000 | +18.8% | 462,000 | 0.0% | 0.84% | +7.0% |
| Q2 2020 | $36,036,000 | +33.4% | 462,000 | 0.0% | 0.78% | -10.5% |
| Q1 2020 | $27,018,000 | -27.0% | 462,000 | 0.0% | 0.88% | -16.1% |
| Q4 2019 | $37,011,000 | +9.0% | 462,000 | 0.0% | 1.04% | -7.0% |
| Q3 2019 | $33,943,000 | -22.1% | 462,000 | 0.0% | 1.12% | -15.3% |
| Q2 2019 | $43,580,000 | +17.8% | 462,000 | 0.0% | 1.32% | +4.1% |
| Q1 2019 | $36,983,000 | +66.5% | 462,000 | +12.1% | 1.27% | +29.5% |
| Q4 2018 | $22,211,000 | +0.9% | 412,000 | +46.1% | 0.98% | +21.7% |
| Q3 2018 | $22,013,000 | +131.2% | 282,000 | +88.0% | 0.81% | +104.6% |
| Q2 2018 | $9,522,000 | -30.8% | 150,000 | 0.0% | 0.40% | -38.7% |
| Q1 2018 | $13,755,000 | +21.6% | 150,000 | 0.0% | 0.64% | +9.2% |
| Q4 2017 | $11,312,000 | -31.2% | 150,000 | -36.4% | 0.59% | -36.7% |
| Q3 2017 | $16,442,000 | +22.4% | 236,000 | -10.9% | 0.93% | +11.5% |
| Q2 2017 | $13,428,000 | +26.7% | 265,000 | 0.0% | 0.84% | +19.1% |
| Q1 2017 | $10,597,000 | +42.6% | 265,000 | 0.0% | 0.70% | +45.0% |
| Q4 2016 | $7,433,000 | -5.6% | 265,000 | 0.0% | 0.48% | +0.6% |
| Q3 2016 | $7,871,000 | +46.7% | 265,000 | 0.0% | 0.48% | +46.6% |
| Q2 2016 | $5,366,000 | +20.6% | 265,000 | +7.5% | 0.33% | +31.7% |
| Q1 2016 | $4,449,000 | -31.5% | 246,500 | 0.0% | 0.25% | -23.4% |
| Q4 2015 | $6,493,000 | +184.4% | 246,500 | +130.4% | 0.32% | +144.4% |
| Q3 2015 | $2,283,000 | – | 107,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 249,598 | $19,469,000 | 17.31% |
| Casdin Capital, LLC | 1,550,000 | $120,900,000 | 7.16% |
| DAFNA Capital Management LLC | 228,089 | $17,791,000 | 5.13% |
| Aquilo Capital Management, LLC | 315,029 | $24,572,000 | 4.96% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,197,989 | $93,443,000 | 3.88% |
| Integral Health Asset Management, LLC | 110,000 | $8,580,000 | 2.57% |
| Ikarian Capital, LLC | 400,000 | $31,200,000 | 2.48% |
| HealthCor Management, L.P. | 743,018 | $57,955,000 | 2.43% |
| SECTORAL ASSET MANAGEMENT INC | 290,583 | $22,665,000 | 2.08% |
| Rock Springs Capital Management LP | 960,029 | $74,882,000 | 2.05% |